These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 35008897)
21. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy. Guo Y; Petrof BJ; Hussain SN Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948 [TBL] [Abstract][Full Text] [Related]
22. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points. Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817 [TBL] [Abstract][Full Text] [Related]
23. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy. Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155 [TBL] [Abstract][Full Text] [Related]
31. Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy. Hindi SM; Sato S; Choi Y; Kumar A Hum Mol Genet; 2014 Mar; 23(6):1492-505. PubMed ID: 24163132 [TBL] [Abstract][Full Text] [Related]
32. Generation of human induced pluripotent stem cell lines with HMOX1 promoter polymorphism and CRISPR/Cas9-mediated deletion of exon 50 of DMD gene. Polak K; Stępniewski J; Ścieżyńska A; Podgórska A; Dulak J; Florczyk-Soluch U Stem Cell Res; 2023 Feb; 66():103004. PubMed ID: 36565681 [TBL] [Abstract][Full Text] [Related]
33. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy. Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042 [TBL] [Abstract][Full Text] [Related]
34. Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in Swiderski K; Read SJ; Chan AS; Chung JD; Trieu J; Naim T; Koopman R; Lynch GS Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960110 [TBL] [Abstract][Full Text] [Related]
35. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy. Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419 [TBL] [Abstract][Full Text] [Related]
36. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783 [TBL] [Abstract][Full Text] [Related]
37. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy. Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757 [TBL] [Abstract][Full Text] [Related]
38. Autophagy as a new therapeutic target in Duchenne muscular dystrophy. De Palma C; Morisi F; Cheli S; Pambianco S; Cappello V; Vezzoli M; Rovere-Querini P; Moggio M; Ripolone M; Francolini M; Sandri M; Clementi E Cell Death Dis; 2012 Nov; 3(11):e418. PubMed ID: 23152054 [TBL] [Abstract][Full Text] [Related]
39. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy. Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826 [TBL] [Abstract][Full Text] [Related]
40. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]